You are here

vaccines

Johnson & Johnson to Seek F.D.A. Authorization for Booster Shot

NY Times, NY

Tue, 10/5/21 - 10:35 am

Emergency Use Authorization

J&J heats up RSV race with new vaccine data

BioPharma Dive

Mon, 10/4/21 - 10:58 pm

clinical trials

FDA to hold advisory meetings for Moderna & J&J boosters, pediatric COVID-19 vaccines

Beckers Hospital Review

Sun, 10/3/21 - 08:41 pm

Moderna Therapeutics

5 FDA approval decisions to watch in the fourth quarter

BioPharma Dive

Sun, 10/3/21 - 08:32 pm

Intra-Cellular Therapies

Moderna Therapeutics

Novartis tightens up its COVID-19 vaccine policy for staff

Pharmaforum

Sun, 10/3/21 - 08:14 pm

vaccine mandates

How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?

Motley Fool

Fri, 10/1/21 - 10:46 am

AstraZeneca releases US COVID-19 vaccine trial results: 5 things to know

Beckers Hospital Review

Thu, 09/30/21 - 11:02 pm

clinical trials

FDA's top vaccine leader explains why Covid-19 'boosters' may really just be the 3rd shot in the primary series

Endpoints

Thu, 09/30/21 - 10:51 am

Pfizer's next-gen Prevnar 20 can be administered with a flu shot, study finds

Fierce Pharma

Wed, 09/29/21 - 11:14 am

Is Vaccine Latecomer Inovio Making a Comeback?

Motley Fool

Wed, 09/29/21 - 11:05 am

clinical trials

Does This Biotech Have the Secret to Conquering Covid Variants?

Motley Fool

Wed, 09/29/21 - 10:59 am

COVID-19 variants

Pfizer launches mRNA flu vaccine trial

Medical Xpress

Tue, 09/28/21 - 11:32 pm

Should the US government share the Moderna COVID vaccine recipe?

RAPS.org

Tue, 09/28/21 - 11:25 pm

Moderna Therapeutics

Sanofi calls it quits on mRNA Covid-19 shots, scrapping vaccine from $3.2B Translate Bio buyout

Endpoints

Tue, 09/28/21 - 11:21 am

FDA's Marks takes over vaccines office as agency prepares to part ways with 2 key officials

Fierce Pharma

Tue, 09/28/21 - 11:11 am

Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping

Fierce Biotech

Tue, 09/28/21 - 11:08 am

clinical trials

CyanVac starts Phase 1 clinical trial for intranasal COVID-19 vaccine

Biopharma Reporter

Mon, 09/27/21 - 10:58 am

Blue Lake Biotechnology

clinical trials

intranasal vaccines

Is Novavax Delaying Its COVID Vaccine EUA Filings Yet Again?

Motley Fool

Sun, 09/26/21 - 11:25 pm

CDC director overrules advisors on boosters, recommending third shots for at-risk workers

Endpoints

Fri, 09/24/21 - 12:05 pm

Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight

Fierce Pharma

Fri, 09/24/21 - 11:58 am

pneumococcal disease

Pages